Stop TB Partnership

The Global Plan to Stop TB

Global Plan photo

The Global Plan to Stop TB provides a roadmap for the fight against TB for a five-year period.

The Stop TB Partnership has issued five and ten-year global plans over the last decade and a half. It provides an estimate for the resources needed every five years to achieve the goals the world has set.

The first plan covered the period of 2001 - 2005. The plan was bold in its ambition and was the first of its kind following the Millennium Development Goals. This provided a coherent agenda to rally key new partners, push forward research and development, and have a rapid impact on TB in the areas suffering most from the epidemic It focussed on the expansion of the DOTS strategy and the emerging challenge of rising drug resistance in TB and HIV infection.

In 2006, the Partnership launched the Global Plan to Stop TB 2006-2015 in Davos, Switzerland at the World Economic Forum. The total cost of the Plan - US$56 billion - represented a threefold increase in annual investment in TB control compared with the first Global Plan. The Plan set out to reduce TB incidence in line with the Millennium Development Goals (MDGs) and reach the Partnership’s targets for 2015 of halving TB prevalence and deaths compared with 1990 levels.

A third plan provided an update for the 2011 - 2015 period. It set out what needed to be done to achieve the 2015 targets determined within the context of the MDGs and by the Stop TB Partnership. The plan focussed on scaling up existing interventions for the diagnosis and treatment of TB and introducing new technologies and notably new diagnostic tests.

The Partnership is now working on the new Global Plan to Stop TB 2016 - 2020. The Plan will provide a costed blue-print for how global TB efforts can become significantly more ambitious and effective over the next five years by dramatically changing the way TB programs are run. It will outline what it takes to set the world on the right track to reach the goals set in the post-2015 Global TB Strategy.